Irritable bowel syndrome (IBS) is a disease in which gastrointestinal symptoms-primarily abdominal pain or discomfort and abnormal bowel movements persist chronically. For patients with IBS, mental illness, especially depression and/or anxiety, leads to a further lower quality of life. The purpose of this case study was to investigate the effects of mirtazapine (MIR) on mental health and IBS symptoms in a case of IBS accompanied by anxiety and a depressive state. This case report suggests that MIR is efficacious for the treatment of IBS with predominant diarrhea accompanied by depression and anxiety. (J Nippon Med Sch 2018; 85: 330 333) 
Introduction
Irritable bowel syndrome (IBS) is a disease in which gastrointestinal symptoms-primarily abdominal pain or discomfort and abnormal bowel movements (constipation or diarrhea)-persist chronically. However, IBS is not accompanied by organic abnormalities that explain the symptoms. IBS can be diagnosed according to the diagnostic criteria outlined by Rome IV and is classified by stool abnormality into the following types: IBS with predominant constipation, IBS with predominant diarrhea, IBS with mixed bowel habits, and IBS unclassified 1 . The prevalence of IBS is approximately 10% of the population 2 . IBS itself markedly lowers quality of life (QOL), and 42% to 61% of patients with IBS exhibit comorbid mental health concerns 3 . The comorbidity rate of IBS in patients with mental health conditions is 26.8% to 29.4% for major depressive disorder, 16.7% to 46.3% for panic disorder, and 37% for generalized anxiety disorder 4 . These high comorbidity rates further lower QOL. The purpose of this case study was to investigate the effects of mirtazapine (MIR) on mental health symptoms and IBS symptoms in a case of IBS accompanied by anxiety and a depressive state.
Patient consent for this report was obtained.
Case
The patient was a 52-year-old housewife. She had no history of mental illness and lived with her husband. She had been visiting a nearby physician for treatment of IBS with predominant diarrhea, and she was taking a lactobacillus preparation. She received a preoperative psychiatry consultation after being informed of a diagnosis of ovarian cancer, because anxiety, depressed mood, and insomnia were observed, in addition to her existing diarrhea and abdominal pain.
At the time of her examination, her facial expression was haggard, and she was fidgeting and acting restless.
Feelings of depressed mood, anxiety, and irritability, as well as difficulty falling asleep were observed. However, decreased motivation and loss of appetite were not observed. Based on these symptoms, she was diagnosed with adjustment disorder (mixed depressed mood and anxiety type) based on the DSM-IV-TR 5 . She scored 22 points on the Hamilton Rating Scale for Depression (HAM-D) 6 , and 28 points on the Hamilton Rating Scale for Anxiety (HAM-A) 7 . 
